Literature DB >> 18884900

Studies on a proteolytic enzyme in human plasma; some factors controlling the rate of fibrinolysis.

O D RATNOFF.   

Abstract

Methods are described for the assay of chloroform-activated and fibrinolysin-activated plasma proteolytic enzyme, and for the determination of the inhibitory activity of plasma or other substances against chloroform-activated enzyme. The inhibitory activities of plasma, serum, and crude plasma albumin against chloroform-activated plasma proteolytic enzyme were proportional to the logarithm of the concentration of the inhibitory substance tested. This suggests that enzyme and inhibitor react in accordance with the law of mass action. The rate of fibrinolysis of recalcified plasma clots could not be related to the total proteolytic activity available in the plasma, nor to the inhibitory activity of fresh plasma or serum against plasma proteolytic enzyme. During the incubation of a recalcified plasma clot at 37 degrees C., the inhibitory activity of its serum against plasma proteolytic enzyme decreased until a minimal stationary level was reached. The clot lysis time could be correlated directly with the time which elapsed until this minimal level was reached.

Entities:  

Keywords:  BLOOD/enzymes; BLOOD/fibrin; BLOOD/plasma

Mesh:

Substances:

Year:  1948        PMID: 18884900      PMCID: PMC2135831          DOI: 10.1084/jem.88.4.401

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  1 in total

1.  Studies on a proteolytic enzyme in human plasma; the probable identity of the enzymes activated by chloroform and by filtrates of cultures of beta hemolytic streptococci.

Authors:  O D RATNOFF
Journal:  J Exp Med       Date:  1948-03-01       Impact factor: 14.307

  1 in total
  2 in total

1.  Studies of the plasmin system. II. Inhibition of plasmin by serum or plasma.

Authors:  P S NORMAN
Journal:  J Exp Med       Date:  1958-07-01       Impact factor: 14.307

2.  Observations on the release of serum fibrinolysin by specific antigen, peptone, and certain polysaccharides.

Authors:  G UNGAR; S H MIST
Journal:  J Exp Med       Date:  1949-07       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.